Medifast reported a 19.4% year-over-year revenue decline to $72 million in Q3 2026, with a significant drop in active earning coaches by 47%, despite higher revenue per coach. The company maintains a strong, cash-heavy balance sheet trading near liquidation value, but its business model faces challenges from GLP-1 market disruption and lacks product differentiation. Management changes and activist investor involvement suggest upcoming board-level shifts, though the core multi-level marketing approach remains unchanged. The stock is rated Hold due to downside protection from tangible assets but limited growth potential.
Medifast's recent performance provides context for the Consumer Staples sector, where 15 of 63 stocks rose and 48 fell as of Oct 28, 2026, 13:11 WIB. Among notable movers, XXII surged 27.20% to USD 0.13 with balanced Pluang order activity, while OTLY declined 4.28% to USD 12.19 amid 100% sell orders. STZ traded at USD 130.63, down 3.68%, with a notably short typical hold time of 3 days on Pluang.
Admiral Group PLC repurchased 250,000 of its ordinary shares between October 21 and 27, 2026, as part of its ongoing buy-back program announced in September 2026. The shares were bought through UBS across multiple trading venues at prices around 3,70...
Otto Group and Sereact are introducing up to 25 AI-controlled dual-arm robots at Otto Group’s logistics center in Poland to automate the inspection and sorting of returned items. These robots use Sereact's Cortex Physical AI, powered by NVIDIA techno...
KPN's Supervisory Board has nominated Mayte Oosterveld and Natasja Laheij for appointment to the board, with votes scheduled at the April 2027 Annual General Meeting. Oosterveld brings extensive finance and strategy experience from roles at Just Eat ...
Dassault Systèmes has completed its $1.8 billion acquisition of ArisGlobal, creating a unified AI-native platform that integrates drug discovery, clinical development, manufacturing, and patient outcomes. This platform aims to accelerate innovation a...
Dassault Systèmes has finalized its $1.8 billion acquisition of ArisGlobal, creating a unified AI platform that connects scientific discovery, clinical development, production, and patient outcomes in life sciences. This platform aims to accelerate d...
